SENNA LAX- sennosides 8.6mg tablet 
Allegiant Health

----------

Drug Facts

Active ingredient

Sennosides 8.6mg

Purpose

Laxative

Uses

Warnings

Do not use

laxative products for longer than one week unless directed by a doctor

Ask a doctor before use if you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that continues over a period of 2 weeks 

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of childen.

In case of accidental overdose, contact a doctor or Poison Control Center (1-800-222-1222) right away.

Directions

agestarting Dosagemaximum Dosage
adults and children 12 years of age and over2 tablets once a day4 tablets twice a day
children 6 to under 12 years1 tablet once a day2 tablets twice a day
children 2 to under 6 years½ tablet once a day1 tablet twice a day
children under 2 yearsask a doctorask a doctor

Other information

Inactive ingredients

croscarmellose sodium, dibasic calcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide

Principal Display Panel

Senna Lax

Senna Lax

SENNA LAX 
sennosides 8.6mg tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69168-371
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
ColorbrownScoreno score
ShapeROUNDSize8mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69168-371-3030 in 1 BOTTLE; Type 0: Not a Combination Product07/01/2014
2NDC:69168-371-17300 in 1 BOTTLE; Type 0: Not a Combination Product05/18/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00707/01/2014
Labeler - Allegiant Health (079501930)

Revised: 12/2019
Document Id: 3d9f08e0-645d-4780-93aa-1982483e7b90
Set id: 94a9c24a-07c3-4535-b810-b7abc9fc5ad5
Version: 5
Effective Time: 20191211
 
Allegiant Health